Lunit Inc. (328130.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · South Korea
Lunit Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 54.18 bn KRW | 83.13 bn KRW |
| Gross profit | 53.91 bn KRW | 83.13 bn KRW |
| Operating income | -67.67 bn KRW | -83.12 bn KRW |
| EBIT | -69.80 bn KRW | -21.12 bn KRW |
| Net income | -82.42 bn KRW | -47.39 bn KRW |
| Diluted EPS – continuing operations | -2,854.58 KRW | -756.63 KRW |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Lunit Inc.
Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea. It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer. The company has a strategic collaboration with AstraZeneca for the development of Lunit SCOPE Genotype Predictor, an AI-powered tool capable of analyzing H&E slide images to predict the likelihood of the tumor harboring NSCLC driver mutations, such as Epidermal Growth Factor Receptor mutations; with Agilent Technologies Inc. to create advanced solutions that meet the demand of novel and complex biomarker assays in drug development; and with Daiichi Sankyo Company, Limited to accelerate biomarker discovery and translational research. Lunit Inc. was founded in 2013 and is based in Seoul, South Korea.
More stocks
- McEwen Inc. (MUX)
- Jiangsu Shentong Valve Co Ltd (002438.SZ)
- Akasha Wira International Tbk (ADES.JK)
- Chengdu RML Technology Co. Ltd. (301050.SZ)
- Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246.SZ)
- MediaAlpha, Inc. (MAX)
- Coursera, Inc. (COUR)
- TRUSTCO BANK CORP N Y (TRST)
- Wuhan Fingu Electronic Technology Co Ltd (002194.SZ)
- Charoen Pokphand Enterprise Taiwan Co Ltd (1215.TW)
- Corporación Interamericana de Entretenimiento S.A.B. de C.V (CIEB.MX)
- Northeast Pharmaceutical Group Co Ltd (000597.SZ)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.